1. EP-1457: GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: preliminary safety results. (April 2018) Authors: Meduri, B.; Aluisio, G.; D'Angelo, E.; Tata, C.; Gelsomino, F.; Spallanzani, A.; Ballarin, R.; De Marco, G.; Luppi, G.; Di Benedetto, F.; Cascinu, S.; Lohr, F. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: Implications for second-line trials. (March 2021) Authors: Tovoli, F.; Garajovà, I.; Iavarone, M.; Federico, P.; Gelsomino, F.; Granito, A.; Daniele, B.; Forgione, A.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1047: GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: a prospective trial. (November 2020) Authors: Meduri, B.; Aluisio, G.; D'Angelo, E.; Vernaleone, M.; Tata, C.; Gelsomino, F.; Spallanzani, A.; Ballarin, R.; Luppi, G.; Di Benedetto, F.; Lohr, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗